Lycium barbarum polysaccharide attenuates cardiac hypertrophy, inhibits calpain‑1 expression and inhibits NF‑κB activation in streptozotocin‑induced diabetic rats

Liu,Qianqian; Han,Qianqian; Lu,Meili; Wang,Hongxin; Tang,Futian

doi:10.3892/etm.2019.7612

Lycium barbarum polysaccharide attenuates cardiac hypertrophy, inhibits calpain‑1 expression and inhibits NF‑κB activation in streptozotocin‑induced diabetic rats

Authors:
- Qianqian Liu
- Qianqian Han
- Meili Lu
- Hongxin Wang
- Futian Tang
View Affiliations

Affiliations: Key Laboratory of Cardiovascular and Cerebrovascular Drug Research of Liaoning Province, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China
Published online on: May 24, 2019 https://doi.org/10.3892/etm.2019.7612
Pages: 509-516
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cardiac hypertrophy is one of the key structural changes that occurs in diabetic cardiomyopathy. Previous studies have indicated that the activation of NF‑κB by calpain‑1, a Ca2+‑dependent cysteine protease, serves an important role in cardiac hypertrophy. The aim of the present study was to assess the effect of 30 and 60 mg/kg Lycium barbarum polysaccharide (LBP) treatment, the major active ingredient extracted from Lycium barbarum, on cardiac hypertrophy in streptozotocin (STZ) induced diabetic rats. In addition, the present study examined the possible underlying mechanisms of this effect by assessing calpain‑1 expression and the NF‑κB pathway. The mRNA expression of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) was determined by reverse transcription‑quantitative PCR. Western blotting was used to detect the protein expressions of calpain‑1, interleukin‑6 (IL‑6), tumor necrosis factor‑α (TNF‑α), intercellular adhesion molecule‑1 (ICAM‑1), vascular adhesion molecule‑1 (VCAM‑1) and toll‑like receptor‑4 (TLR‑4) in the heart tissue. The results revealed that compared with non‑diabetic rats, diabetic rats exhibited cardiac hypertrophy. Cardiac hypertrophy was defined by the following: Dysfunction of the cardiac hemodynamics, an increase in the ratios of left ventricular weight/body weight and heart weight/body weight and the increased expressions of ANP and BNP, which serve as hypertrophic markers in cardiac tissue. However, all of these changes were attenuated in diabetic rats treated with LBP. In addition, the protein expression of calpain‑1 was increased in the heart tissue of diabetic rats compared with that of non‑diabetic rats, where it was inhibited by LBP. LBP also decreased the protein expression of certain inflammatory mediators, IL‑6, TNF‑α, ICAM‑1, VCAM‑1 and TLR‑4 in diabetic heart tissue. Furthermore, LBP treatment reduced the production of reactive oxygen species, upregulated the protein expression of endothelial nitric oxide synthase and downregulated the protein expression of inducible nitric‑oxide synthase. Additionally, LBP increased the protein expression of p65, the subunit of NF‑κB and inhibitory protein кB‑α in the cytoplasm and reduced p65 expression in the nucleus. In conclusion, LBP improves cardiac hypertrophy, inhibits the expression of calpain‑1 and inhibits the activation of NF‑κB in diabetic rats.

View Figures

View References

1	Zhang J, Qiu H, Huang J, Ding S, Huang B, Wu Q and Jiang Q: Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice. Biochem Biophys Res Commun. 502:55–61. 2018. View Article : Google Scholar : PubMed/NCBI
2	Li Y, Ma J, Zhu H, Singh M, Hill D, Greer PA, Arnold JM, Abel ED and Peng T: Targeted inhibition of calpain reduces myocardial hypertrophy and fibrosis in mouse models of type 1 diabetes. Diabetes. 60:2985–2994. 2011. View Article : Google Scholar : PubMed/NCBI
3	Negishi K: Echocardiographic feature of diabetic cardiomyopathy: Where are we now? Cardiovasc Diagn Ther. 8:47–56. 2018. View Article : Google Scholar : PubMed/NCBI
4	Yan M, Chen K, He L, Li S, Huang D and Li J: Uric acid induces cardiomyocyte apoptosis via activation of calpain-1 and endoplasmic reticulum stress. Cell Physiol Biochem. 45:2122–2135. 2018. View Article : Google Scholar : PubMed/NCBI
5	Hua Y and Nair S: Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications. Biochim Biophys Acta. 1852:195–208. 2015. View Article : Google Scholar : PubMed/NCBI
6	Chen B, Zhao Q, Ni R, Tang F, Shan L, Cepinskas I, Cepinskas G, Wang W, Schiller PW and Peng T: Inhibition of calpain reduces oxidative stress and attenuates endothelial dysfunction in diabetes. Cardiovasc Diabetol. 13:882014. View Article : Google Scholar : PubMed/NCBI
7	Yu L, Yin M, Yang X, Lu M, Tang F and Wang H: Calpain inhibitor I attenuates atherosclerosis and inflammation in atherosclerotic rats through eNOS/NO/NF-κB pathway. Can J Physiol Pharmacol. 96:60–67. 2018. View Article : Google Scholar : PubMed/NCBI
8	Mei M, Tang F, Lu M, He X, Wang H, Hou X, Hu J, Xu C and Han R: Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation. Environ Toxicol Pharmacol. 40:764–773. 2015. View Article : Google Scholar : PubMed/NCBI
9	Xu T, Zhang B, Yang F, Cai C, Wang G, Han Q and Zou L: HSF1 and NF-κB p65 participate in the process of exercise preconditioning attenuating pressure overload-induced pathological cardiac hypertrophy. Biochem Biophys Res Commun. 460:622–627. 2015. View Article : Google Scholar : PubMed/NCBI
10	Xu C, Tang F, Lu M, Yang J, Han R, Mei M, Hu J, Zhou M and Wang H: Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways. Int Immunopharmacol. 33:119–127. 2016. View Article : Google Scholar : PubMed/NCBI
11	Zuo G, Ren X, Qian X, Ye P, Luo J, Gao X, Zhang J and Chen S: Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy. J Cell Physiol. 234:1925–1936. 2019. View Article : Google Scholar : PubMed/NCBI
12	Wang Y, Huang X, Ma Z, Wang Y, Chen X and Gao Y: Ophiopogonin D alleviates cardiac hypertrophy in rat by upregulating CYP2J3 in vitro and suppressing inflammation in vivo. Biochem Biophys Res Commun. 503:1011–1019. 2018. View Article : Google Scholar : PubMed/NCBI
13	Yun JM, Jialal I and Devaraj S: Epigenetic regulation of high glucose-induced proinflammatory cytokine production in monocytes by curcumin. J Nutr Biochem. 22:450–458. 2011. View Article : Google Scholar : PubMed/NCBI
14	Zou J, Li H, Chen X, Zeng S, Ye J, Zhou C, Liu M, Zhang L, Yu N, Gan X, et al: C/EBPβ knockdown protects cardiomyocytes from hypertrophy via inhibition of p65-NFκssssB. Mol Cell Endocrinol. 390:18–25. 2014. View Article : Google Scholar : PubMed/NCBI
15	Tang HL, Chen C, Wang SK and Sun GJ: Biochemical analysis and hypoglycemic activity of a polysaccharide isolated from the fruit of Lycium barbarum L. Int J Biol Macromol. 77:235–242. 2015. View Article : Google Scholar : PubMed/NCBI
16	Yang DM, Zhang JQ and Fei YF: Lycium barbarum polysaccharide attenuates chemotherapy-induced ovarian injury by reducing oxidative stress. J Obstet Gynaecol Res. 43:1621–1628. 2017. View Article : Google Scholar : PubMed/NCBI
17	Chen S, Liang L, Wang Y, Diao J, Zhao C, Chen G, He Y, Luo C, Wu X and Zhang Y: Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo. Mol Med Rep. 12:6727–6737. 2015. View Article : Google Scholar : PubMed/NCBI
18	Du M, Hu X, Kou L, Zhang B and Zhang C: Lycium barbarum polysaccharide mediated the antidiabetic and antinephritic effects in diet-streptozotocin-induced diabetic sprague dawley rats via regulation of NF-κB. Biomed Res Int. 2016:31402902016. View Article : Google Scholar : PubMed/NCBI
19	Shi GJ, Zheng J, Han XX, Jiang YP, Li ZM, Wu J, Chang Q, Niu Y, Sun T, Li YX, et al: Lycium barbarum polysaccharide attenuates diabetic testicular dysfunction via inhibition of the PI3K/Akt pathway-mediated abnormal autophagy in male mice. Cell Tissue Res. 374:653–666. 2018. View Article : Google Scholar : PubMed/NCBI
20	Liu SY, Chen L, Li XC, Hu QK and He LJ: Lycium barbarum polysaccharide protects diabetic peripheral neuropathy by enhancing autophagy via mTOR/p70S6K inhibition in Streptozotocin-induced diabetic rats. J Chem Neuroanat. 89:37–42. 2018. View Article : Google Scholar : PubMed/NCBI
21	Shi GJ, Zheng J, Wu J, Qiao HQ, Chang Q, Niu Y, Sun T, Li YX and Yu JQ: Protective effects of Lycium barbarum polysaccharide on male sexual dysfunction and fertility impairments by activating hypothalamic pituitary gonadal axis in streptozotocin-induced type-1 diabetic male mice. Endocr J. 64:907–922. 2017. View Article : Google Scholar : PubMed/NCBI
22	Shi GJ, Zheng J, Wu J, Qiao HQ, Chang Q, Niu Y, Sun T, Li YX and Yu JQ: Beneficial effects of Lycium barbarum polysaccharide on spermatogenesis by improving antioxidant activity and inhibiting apoptosis in streptozotocin-induced diabetic male mice. Food Funct. 8:1215–1226. 2017. View Article : Google Scholar : PubMed/NCBI
23	Zhao R, Li QW, Li J and Zhang T: Protective effect of Lycium barbarum polysaccharide 4 on kidneys in streptozotocin-induced diabetic rats. Can J Physiol Pharmacol. 87:711–719. 2009. View Article : Google Scholar : PubMed/NCBI
24	National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, . Guide for the Care and Use of Laboratory Animals, 8th edition. National Academies Press (US); Washington, DC: 2011
25	Tang F, Lu M, Yu L, Wang Q, Mei M, Xu C, Han R, Hu J, Wang H and Zhang Y: Inhibition of TNF-α-mediated NF-κB Activation by Ginsenoside Rg1 Contributes the Attenuation of Cardiac Hypertrophy Induced by Abdominal Aorta Coarctation. J Cardiovasc Pharmacol. 68:257–264. 2016. View Article : Google Scholar : PubMed/NCBI
26	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
27	Alvarez BV, Quon AL, Mullen J and Casey JR: Quantification of carbonic anhydrase gene expression in ventricle of hypertrophic and failing human heart. BMC Cardiovasc Disord. 13:22013. View Article : Google Scholar : PubMed/NCBI
28	Cai H, Liu F, Zuo P, Huang G, Song Z, Wang T, Lu H, Guo F, Han C and Sun G: Practical application of antidiabetic efficacy of Lycium barbarum polysaccharide in patients with type 2 diabetes. Med Chem. 11:383–390. 2015. View Article : Google Scholar : PubMed/NCBI
29	Guo Y, Zhuang X, Huang Z, Zou J, Yang D, Hu X, Du Z, Wang L and Liao X: Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo. Biochim Biophys Acta Mol Basis Dis. 1864:238–251. 2018. View Article : Google Scholar : PubMed/NCBI
30	Ni R, Zheng D, Xiong S, Hill DJ, Sun T, Gardiner RB, Fan GC, Lu Y, Abel ED, Greer PA and Peng T: mitochondrial calpain-1 disrupts atp synthase and induces superoxide generation in type 1 diabetic hearts: A novel mechanism contributing to diabetic cardiomyopathy. Diabetes. 65:255–268. 2016.PubMed/NCBI